Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Tubulis’ next-generation antibody-drug conjugate (ADC) has been tied to an overall response rate (ORR) of 59% as the German ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...

The number of CT machines in Israel is limited, and waiting times can be long. An AI–based system has succeeded in shortening ...

Seven Roman soldiers' remains found in a Croatian well may be tied to the 260 CE Battle of Mursa, revealing brutal deaths ...

Nagpur: As the festive season begins, city doctors are reporting a steady rise in H3N2 influenza and Respiratory Syncytial ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

Johnson & Johnson (NYSE:JNJ) today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with ...

Surprising DIYs are illegal across states, from backyard builds to energy hacks. Learn laws, risks, and safer alternatives.

Gilead Sciences, Inc. will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, ...

Shoppers at TK Maxx, John Lewis, Primark, B&M and Amazon have been warned to stop using some products sold at the stores ...